Predictores e impacto de la adopción de programación basada en la evidencia en la incidencia de terapias del desfibrilador automático implantable

Loughlin, Gerard; Datino, Tomás; Arenal, Ángel; Ruiz-Granell, Ricardo; Sánchez-Gómez, Juan Miguel; Pérez, Luisa; Martínez-Ferrer, José; Alzueta, Javier; Pérez-Lorente, Fernando; Viñolas, Xavier.
Rev. esp. cardiol. (Ed. impr.) ; 74(4): 296-302, Abr. 2021. tab, graf
Artículo en Español | IBECS (España) | ID: ibc-232234

Documentos relacionados

  1. Predictors of adoption and impact of evidence-based programming on the incidence of implantable cardioverter-defibrillator therapies.
  2. Snapshot: Trial Types in Precision Medicine.
  3. Recommendations for robust and reproducible preclinical research in personalised medicine.
  4. Practical guidance on modeling choices for the virtual twins method.
  5. A general framework for subgroup detection via one-step value difference estimation.
  6. How Machine Learning Will Transform Biomedicine.
  7. Estimation and evaluation of individualized treatment rules following multiple imputation.
  8. The gaps between the new EU legislation on <i>in vitro</i> diagnostics and the on-the-ground reality.
  9. Comment on 'statistical consideration and challenges in bridging study of personalized medicine': a modified variance for sensitivity analysis.
  10. CM-Path Molecular Diagnostics Forum-consensus statement on the development and implementation of molecular diagnostic tests in the United Kingdom.